Origins
When was Melanotan I created?
Melanotan I came out of a University of Arizona programme that was substituting residues into alpha-MSH to stop the body taking it apart so quickly.
The short answer
| Date | The 1980s |
| Who | Victor Hruby, Mac Hadley and colleagues |
| Where | University of Arizona, Tucson |
| Origin | Designed, not found — it does not occur naturally in this form. |
Where it came from
Alpha-melanocyte-stimulating hormone is a thirteen-residue chain that does not last long in blood. The Arizona group, led by the peptide chemist Victor Hruby with the endocrinologist Mac Hadley, worked through analogues looking for ones that survived longer and bound more tightly.
Two substitutions did most of the work: norleucine in place of the methionine at position 4, which removes a residue prone to oxidation, and the D-form of phenylalanine at position 7 in place of the natural L-form. Enzymes that cut peptide chains are built around L-amino acids and are much slower on D ones, so the swap buys the whole chain time. The result is written [Nle4, D-Phe7]-α-MSH, and it is Melanotan I.
The precise year depends on which paper you count — the substitution work ran across the decade — so the honest answer is the 1980s rather than a single date.
Why it is called that
Melanotan was the programme’s own name for the series. The compound later received the international nonproprietary name afamelanotide, which is what it is called in the approval literature.
Where it stands now
Afamelanotide was approved in Europe in 2014 and in the United States in 2019, for a rare light-sensitivity disorder. The material supplied for laboratory work is not that product.
What this page does not say
Nothing above is a statement about what Melanotan I does in a body, and none of it is guidance on use. A compound’s history is a record of laboratories and dates; it is not evidence for anything, and the fact that a programme was looking for something is not a finding that it was found.
More on Melanotan I
What is Melanotan I? · The full timeline · Melanotan I — sizes and prices
